Cell CycleCell BiologyPeer-reviewed journal article
Baseline cell proliferation rates and response to UV differ in Lymphoblastoid Cell Lines derived from healthy individuals of extreme constitution types
S. Chakraborty, S. Singhmar, D. Singh, M. Maulik, R. Patil, S. K. Agrawal, A. Mishra, M. Ghazi, A. Vats, v. T. Natarajan, S. Juvekar, B. Prasher, M. Mukerji
Abstract
Differences in human phenotypes and susceptibility to complex diseases are an outcome of genetic and environmental interactions. This is evident in diseases that progress through a common set of intermediate patho-endophenotypes. Precision medicine aims to delineate the molecular players for individualized and early interventions. Functional studies in Lymphoblastoid Cell Line (LCL) model of phenotypically well characterized healthy individuals can help deconvolute and validate these molecular mechanisms. We developed LCLs from eight healthy individuals belonging to three extreme constitution types, deep phenotyped on the basis of Ayurveda. LCLs were characterized by karyotyping and immunophenotyping. Growth characteristics and response to UV was studied in these LCLs. We observed significant differences in cell proliferation rates between the contrasting groups such that one type (Kapha) proliferates significantly slower than the other two (Vata, Pitta). In response to UV, one fast growing group (Vata) shows higher cell death but recovers its numbers due to inherent higher rates of proliferation. The baseline differences in cell proliferation are key to understanding the survival of cells in UV stress. Variability in baseline cellular phenotypes not only explains the cellular basis of different constitutions types but can also help set priors during designing an individualized therapy with DNA damaging agents. This is the first study of its kind that shows variability of intermediate patho-phenotypes amongst healthy individuals that have implications in precision medicine.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptomic profiling of healthy individual-derived LCLs revealed inter-individual variability towards-hypoxia-responsive pathways
Dayanidhi Singh, Komal Mehta, … Bhavana Prasher·bioRxiv·Aug 6, 2024
- Proliferating CLL cells express high levels of CXCR4 and CD5
D. Friedman, D. P. Mehtani, … R. Hoogeboom·bioRxiv·Dec 27, 2023
- Cell type-specific differences in redox regulation and proliferation after low UVA doses
S. Ciesielska, P. Bil, … J. Rzeszowska-Wolny·bioRxiv·Sep 24, 2018
- A single-cell multi-omic and spatial atlas of B cell lymphomas reveals differentiation drives intratumor heterogeneity
D. Fitzgerald, T. Roider, … W. Huber·bioRxiv·Nov 6, 2023
- Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation
J. Griss, S. Gansberger, … P. M. Brunner·bioRxiv·Dec 16, 2022
- Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia
Simone Ecker, Vera Pancaldi, … Alfonso Valencia·bioRxiv·Sep 3, 2014